← Back to Search

Medical Device Usage and Evaluation for Type 2 Diabetes

N/A
Waitlist Available
Led By Kathleen M Dungan, MD, MPH
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately following inpatient hospitalization
Awards & highlights

Study Summary

This trial will study if adding a continuous glucose monitor application to diabetes treatment plans will improve patient satisfaction and reduce diabetes distress.

Eligible Conditions
  • Type 2 Diabetes
  • Blood Cancers
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from week 1 to week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and from week 1 to week 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Diabetes Treatment Satisfaction Questionnaire (DTSQ) survey score
Secondary outcome measures
Change in DTSQ scores
Change in Patient Health Questionnaire scores
Change in various measures of control
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (CGM)Experimental Treatment3 Interventions
Prior to hospital discharge, patients receive CGM application and education on how to apply the CGM, and how to use the sensor and its associated smart phone app. Patients also receive basic diabetes mellitus education. After hospital discharge, patients use CGM for up to 28 days.

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,164 Total Patients Enrolled
Kathleen M Dungan, MD, MPHPrincipal InvestigatorOhio State University Comprehensive Cancer Center
1 Previous Clinical Trials
8 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to sign up for this clinical experiment?

"Based on the information hosted by clinicaltrials.gov, this trial is not currently recruiting participants and has not been updated since June 17th 2021. However, there are 3844 other trials around the world that are still open for enrollment at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer
Kathleen Dungan 2021. "Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04938869.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top